ArticleJournal of Korean medical science2011
Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry.
Article in Journal of Korean medical science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2022Pooled it
- Fracture and plastering of distal left main stent during double-kissing Culotte technique: a case report.European heart journal. Case reports · 2024Article
- Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.Current cardiology reviews · 2023Review
- Coronary Stent Fracture Causing Myocardial Infarction: Case Report and Review of Literature.Reviews in cardiovascular medicine · 2022Review
- Advantages and prospects of optical coherence tomography in interventional therapy of coronary heart disease (Review).Experimental and therapeutic medicine · 2022Review
- Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations.Journal of clinical medicine · 2021Article
- Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5 Year Period in FDA MAUDE Database.Annals of biomedical engineering · 2016Article
- Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost.SAGE open medical case reports · 2016Article
- Acute ST-Elevation Myocardial Infarction after Coronary Stent Fracture.The journal of Tehran Heart Center · 2015Article
- Coronary stent fracture: a recently appreciated phenomenon with clinical relevance.Current cardiology reviews · 2014Review
- Impact of stent mis-sizing and mis-positioning on coronary fluid wall shear and intramural stress.Journal of applied physiology (Bethesda, Md. : 1985) · 2013Article
- Stent fracture: how frequently is it recognized?Heart views : the official journal of the Gulf Heart Association · 2013Article
- Prevalence and prognosis of coronary stent gap detected by multi-detector CT: a follow-up study.European radiology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stent fracture (SF) has been implicated as a risk factor for in-stent restenosis, but its incidence and clinical characteristics are not well established. Therefore we investigated the conditions associated with stent fracture and its clinical presentation and outcome. Between 2004 and 2007, consecutive cases of SF were collected from the Seoul National University Hospital. Clinical characteristics and outcome of patients with fractured stents were compared with a ten-fold cohort of age and gender matched controls (n = 236). A total of 4,845 patients received percutaneous coronary intervention and 3,315 patients (68.4%) underwent angiographic follow-up. Twenty-eight fractured stents were observed in 24 patients. The incidence of SF was 0.89% for sirolimus-eluting stents (SES) and 0.09% for paclitaxel-eluting stents. Chronic kidney disease, stent implantation in the right coronary artery (RCA), and SES use were independent predictors of drug-eluting stent fracture by multivariate analysis. SF was significantly associated with binary restenosis (11.4% vs 41.7%, P < 0.001) and increased risk of target lesion revascularization (8.1% vs 33.3%, P = 0.001). Patients with SF but without significant restenosis showed excellent outcome despite only medical treatment. In conclusion, SF is associated with increased rates of restenosis and repeat revascularization. Significant risk factors include chronic kidney disease, RCA intervention, and SES use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.